Cargando...
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
BACKGROUND: Vortioxetine is the first mixed serotonin agonist and antagonist antidepressant approved in the US. We sought to evaluate all published and unpublished data available to determine the efficacy and harms of vortioxetine in adults with major depressive disorder. METHODS: We used a predefin...
Gardado en:
| Publicado en: | Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4351824/ https://ncbi.nlm.nih.gov/pubmed/25874839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-015-0001-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|